Sangamo Therapeutics Inc Cash Flow Reinvestment Rate
Sangamo Therapeutics Inc cash flow reinvestment rate. Sangamo Therapeutics Inc (SGMO) has a Cash Flow Reinvestment Rate of 0.03x as of September 2024, reinvesting $348.00K (capex $115.00K plus investments $233.00K) from operating cash flow of $11.76 Million. Explore SGMO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sangamo Therapeutics Inc (2017–2020)
Cash flow reinvestment rate of Sangamo Therapeutics Inc from 2017 to 2020. Historical reinvestment intensity for Sangamo Therapeutics Inc across 3 annual periods. Explore Sangamo Therapeutics Inc (SGMO) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Sangamo Therapeutics Inc Cash Flow Reinvestment Rate by Year (2017–2020)
Sangamo Therapeutics Inc cash flow reinvestment rate by year from 2017 to 2020. Year-by-year capital reinvestment analysis for Sangamo Therapeutics Inc. For the full cash flow conversion analysis, see Sangamo Therapeutics Inc (SGMO) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.59x | $270.92 Million | $169.88 Million | $14.71 Million | ▼ -42.2% |
| 2018 | 2.76x | $102.46 Million | $37.15 Million | $43.06 Million | ▼ -60.2% |
| 2017 | 6.92x | $77.40 Million | $11.18 Million | $3.75 Million | — |